Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Buy
54
ACLX Quote, Financials, Valuation and Earnings
Last price:
$63.44
Seasonality move
:
1.31%
Day range:
$64.90 - $66.67
52-week range:
$47.86 - $107.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
46.56x
P/B ratio:
8.72x
Volume:
514.5K
Avg. volume:
894.8K
1-year change:
18.3%
Market cap:
$3.6B
Revenue:
$107.9M
EPS (TTM):
-$2.99
Analysts' Opinion
-
Consensus RatingArcellx has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $111.21, Arcellx has an estimated upside of 68.51% from its current price of $66.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $93.00 representing -40.91% downside risk from its current price of $66.00.
Fair Value
-
According to the consensus of 11 analysts, Arcellx has 68.51% upside to fair value with a price target of $111.21 per share.
ACLX vs. S&P 500
-
Over the past 5 trading days, Arcellx has underperformed the S&P 500 by -2.7% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Arcellx does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arcellx revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Arcellx reported revenues of $8.1M.
Earnings Growth
-
Arcellx has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Arcellx reported earnings per share of -$1.13.
Enterprise value:
3.1B
EV / Invested capital:
7.42x
Price / LTM sales:
46.56x
EV / EBIT:
--
EV / Revenue:
40.28x
PEG ratio (5yr expected):
-0.12x
EV / Free cash flow:
-25.26x
Price / Operating cash flow:
895.28x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-22.32%
Net Income Margin (TTM):
-211.46%
Return On Equity:
-34.73%
Return On Invested Capital:
-34.73%
Operating Margin:
-847.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | $131.7M | $76.8M | $39.3M | $8.1M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$195.6M | -$75.2M | -$190.7M | -$15.8M | -$68.9M | |
| EBITDA | -$185.4M | -$44.4M | -$154M | -$5.8M | -$60.7M | |
| Diluted EPS | -$4.30 | -$1.03 | -$2.99 | -$0.14 | -$1.13 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $220.9M | $571.4M | $588.7M | $554.2M | |
| Total Assets | -- | $243.4M | $622.9M | $779.7M | $648.1M | |
| Current Liabilities | -- | $16.8M | $166.1M | $107.9M | $112.5M | |
| Total Liabilities | -- | $21.8M | $319.2M | $283.1M | $231.2M | |
| Total Equity | -- | $221.6M | $303.7M | $496.6M | $416.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $115.3M | -$6.4M | -$114.7M | -$31.9M | -$63.1M | |
| Cash From Investing | -$173.8M | -$294.6M | $61.6M | -$206.8M | $37.8M | |
| Cash From Financing | $208.5M | $180.7M | -$20.6M | -$3M | $543K | |
| Free Cash Flow | $112.5M | -$33.3M | -$122.5M | -$38.3M | -$63.9M | |
ACLX
Sector
Market Cap
$3.6B
$32.3M
Price % of 52-Week High
61.47%
46.89%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
18.3%
-37.62%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$66.50
200-day SMA
Sell
Level
$73.25
Bollinger Bands (100)
Buy
Level
59.93 - 68.73
Chaikin Money Flow
Buy
Level
17.3M
20-day SMA
Buy
Level
$64.02
Relative Strength Index (RSI14)
Buy
Level
56.27
ADX Line
Buy
Level
19.72
Williams %R
Neutral
Level
-36.5893
50-day SMA
Buy
Level
$61.82
MACD (12, 26)
Buy
Level
1.38
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
12.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.2282)
Sell
CA Score
(Annual)
Level (-0.5086)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.108)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Stock Forecast FAQ
In the current month, ACLX has received 11 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ACLX average analyst price target in the past 3 months is $111.21.
-
Where Will Arcellx Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arcellx share price will rise to $111.21 per share over the next 12 months.
-
What Do Analysts Say About Arcellx?
Analysts are divided on their view about Arcellx share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arcellx is a Sell and believe this share price will drop from its current level to $93.00.
-
What Is Arcellx's Price Target?
The price target for Arcellx over the next 1-year time period is forecast to be $111.21 according to 11 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ACLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arcellx is a Buy. 11 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ACLX?
You can purchase shares of Arcellx via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arcellx shares.
-
What Is The Arcellx Share Price Today?
Arcellx was last trading at $63.44 per share. This represents the most recent stock quote for Arcellx. Yesterday, Arcellx closed at $66.00 per share.
-
How To Buy Arcellx Stock Online?
In order to purchase Arcellx stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TTD The Big Winner If Pharma Ads Are Banned?
Last week, Senators Bernie Sanders and Angus King introduced a…
Is Palantir Stock Overvalued?
By every traditional yardstick, including a price‑to‑sales well above 100,…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
11
VEON alert for Jun 16
VEON [VEON] is up 4.22% over the past day.
Buy
74
DAVE alert for Jun 16
Dave [DAVE] is up 3.34% over the past day.
Buy
54
DAR alert for Jun 16
Darling Ingredients [DAR] is up 7.05% over the past day.
